Navigation Links
Helix BioPharma announces Q1 2008 financial results
Date:12/17/2007

ment collaborations, and other strategic alliances, which, if obtained, may reduce the Company's interest in its projects or products. There can be no assurance, however, that any alternative sources of funding will be available.

The Company's unaudited interim consolidated first quarter fiscal 2007 and 2006 financial statements are summarized below:

-------------------------------------------------------------------------

Consolidated Statements of Operations

for the three month period ended October 31

(thousand $, except for per share data)

2007 2006

---------------------------

Revenue:

Product revenue 754 696

License fees and royalties 131 130

Research and development contracts - -

---------------------------

885 826

Expenses:

Cost of sales 313 290

Research and development 782 871

Operating, general and admin 1,313 906

Amortization of intangibles 7 40

Amortization of capital assets 66 77

Stock-based compensation 12 12

Interest income, net (104) (102)

Foreign exchange loss 108 45

---------------------------

2,497 2,139

Loss before income taxes
'/>"/>

SOURCE Helix BioPharma Corp.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related biology technology :

1. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
2. Helix BioPharma Chairman resigns
3. Helix BioPharma Corp. announces fiscal 2007 results
4. Helix BioPharma Corp. announces management changes
5. Helix BioPharma announces $16.9 million private placement of common shares
6. China Biopharmaceuticals Holdings Announces Second Quarter 2007 Financial Results
7. XTL Biopharmaceuticals Announces Financial Results for the Six Months Ended June 30, 2007
8. PDL BioPharma Announces Internal CEO Investigation Found No Credible Evidence of Improper Personal Conduct or Breach of Fiduciary Duty
9. Nabi Biopharmaceuticals to Present at Upcoming Industry Conferences
10. PDL BioPharma Announces Significant Strategic and Portfolio Changes to Focus on Antibody Discovery and Development
11. XTL Biopharmaceuticals Announces Presentation of Novel Pre-Clinical Inhibitors of Hepatitis C at an Upcoming International Scientific Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... German . , The ... a semiconductor layer. Quantum dots are small structures that spontaneously ... short laser pulse is fired at the photonic crystal, its ... change in the electromagnetic field around it. This change can ... the dot. As soon as the refractive index recovers its ...
(Date:9/30/2014)... Sept. 30, 2014 Pacific Northwest Biotechnology, ... Summary Global Markets Direct,s, ,Pacific Northwest Biotechnology, ... an overview of the Pacific Northwest Biotechnology, LLC,s ... provides comprehensive information on the current therapeutic developmental ... comparative analysis at various stages, therapeutics assessment by ...
(Date:9/30/2014)... (PRWEB) September 30, 2014 Over the ... primarily due to rising R&D budgets and increased acceptance ... fast growing pharmaceutical and biotechnology industries are also catalyzing ... laboratory filtration market is expected to grow at a ... is estimated to be worth $2,532.6 million by 2019. ...
(Date:9/30/2014)... 30, 2014 CORD:USE Cord Blood Bank – ... it has entered into an Equity and Exclusive Services ... licensed a series of patented technologies for the isolation of ... applications.  Tianhe is performing Phase I/II clinical trials in ... using Tianhe,s Stem Cell Educator Therapy showing ...
Breaking Biology Technology:Ultrafast remote switching of light emission 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 2Pacific Northwest Biotechnology, LLC - Product Pipeline Review - 2014 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 2Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 3Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 4Global Laboratory Filtration Market To See 7.0% CAGR to 2019 Says a Research Report Available at ReportsnReports.com 5CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 2CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 3CORD:USE is Pleased to Announce it has Partnered with Tianhe Stem Cell Biotechnologies, Developer of Cord Blood Stem Cell Therapy Showing Promising Results in Clinical Trials for the Treatment of Diabetes and Autoimmune Diseases 4
... Graphene is nature,s thinnest elastic material and displays ... planar geometry, high current-carrying capacity and thermal conductivity ... through ultra-small devices and components for semiconductor circuits ... features is ripples, similar to those seen on ...
... , PRINCETON, N.J., July 24 ... from around the world who gather at InformexUSA 2010 will experience ... allowing them to connect more precisely with others in their specific ... show opens February 16, 2010 in San Francisco, with a new ...
... BOTHELL, WA and VANCOUVER, July 24 /PRNewswire-FirstCall/ - OncoGenex Pharmaceuticals, ... has completed its registered direct offering, previously announced on July ... institutional investors at a price of $20.00 per share, for ... $20 offering price represented a 3.5% discount to the closing ...
Cached Biology Technology:UCR scientists manipulate ripples in graphene, enabling strain-based graphene electronics 2UCR scientists manipulate ripples in graphene, enabling strain-based graphene electronics 3Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 2Informex Rebrands Into Separate Pharmaceutical and Specialty Chemical Segments to Better Serve Exhibitors and Attendees 3OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering 2OncoGenex Pharmaceuticals Completes $9.5 Million Registered Direct Offering 3
(Date:10/1/2014)... microbes that thrive in the deserts, rainforests, prairies and ... beneath New York City,s Central Park, according to a ... the University of Colorado Boulder. , The research ... Park,s 843 acres and discovered a stunning diversity of ... before. , Only 8.5 percent to 16.2 percent ...
(Date:9/30/2014)... EVANSTON, Ill. --- Do we think of nature as something ... something we need to "preserve?" Or do we think of ... a part of nature, but what about a house? ... They are also reflected in our actions, our speech and ... partnership with the University of Washington, the American Indian Center ...
(Date:9/30/2014)... The National Institutes of Health (NIH) awarded Lawrence ... develop an electrode array system that will enable ... through unprecedented resolution and scale. , LLNL,s grant-funded ... President Obama,s BRAIN (Brain Research through Advancing ... to revolutionize our understanding of the human mind ...
Breaking Biology News(10 mins):Microbes in Central Park soil: If they can make it there, they can make it anywhere 2Microbes in Central Park soil: If they can make it there, they can make it anywhere 3The cultural side of science communication 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 2NIH taps lab to develop sophisticated electrode array system to monitor brain act 3
... Cassava experts are reporting new outbreaks and the increased spread ... rapidly proliferating plant virus could cause a 50 percent drop ... of food and income for 300 million Africans. , ... agriculture experts have been looking to the otherwise resilient cassava ...
... United States suffer from epilepsies, a group of neurological ... brain which often produce debilitating seizures. Although anti-epileptic ... of patients, the remaining one-third do not respond to ... can experience harmful side effects. NIH funded researchers at ...
... Energy Joint Genome Institute (DOE JGI) is among the ... on their potential applications in the fields of bioenergy ... JGI is also focused on developing tools that more ... that it, as well as other genome centers, generates. ...
Cached Biology News:Scientists alarmed by rapid spread of Brown Streak Disease in cassava 2Scientists alarmed by rapid spread of Brown Streak Disease in cassava 3Scientists alarmed by rapid spread of Brown Streak Disease in cassava 4A new cost-effective genome assembly process 2A new cost-effective genome assembly process 3
... The DNA120 is a dedicated concentrator for ... precipitates of DNA/RNA. The integrated system combines ... pump. The compact design, automatic pump and ... run time; one for heater time), makes ...
... (For small quantities of solvents with DNA ... concentrator/centrifugal evaporator systems respond to specific applications ... and safe concentration of heat-labile samples. The ... different of cold traps and a wide ...
... The Jouan RC10 series of vacuum ... product protection features allied to rapid and ... modules can be combined with oil-free or ... traps and a wide selection of rotors ...
For relative and/or absolute quantification with standard accuracy requirements using MS or NMR instruments...
Biology Products: